Diagnosis and management of novel influenza a (H1N1)

Seong Heon Wie, Woo Joo Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Since the World Health Organization has offi cially declared a global influenza pandemic, the number of human cases of pandemic influenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of influenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel influenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel influenza A.

Original languageEnglish
Pages (from-to)843-847
Number of pages5
JournalKorean Journal of Family Medicine
Volume30
Issue number11
DOIs
Publication statusPublished - 2009 Nov 1

Fingerprint

Human Influenza
Pandemics
Zanamivir
Nucleic Acid Amplification Techniques
Oseltamivir
Chills
Pharyngitis
Myalgia
Neuraminidase
Centers for Disease Control and Prevention (U.S.)
Nose
Cough
Antiviral Agents
Fatigue
Disease Outbreaks
Headache
Real-Time Polymerase Chain Reaction
Immunity
Vaccination
Fever

Keywords

  • Novel influenza a (H1N1)
  • Oseltamivir
  • Zanamivir

ASJC Scopus subject areas

  • Family Practice

Cite this

Diagnosis and management of novel influenza a (H1N1). / Wie, Seong Heon; Kim, Woo Joo.

In: Korean Journal of Family Medicine, Vol. 30, No. 11, 01.11.2009, p. 843-847.

Research output: Contribution to journalArticle

@article{c8ff25e8badf4ac7a74e2f4661520097,
title = "Diagnosis and management of novel influenza a (H1N1)",
abstract = "Since the World Health Organization has offi cially declared a global influenza pandemic, the number of human cases of pandemic influenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of influenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel influenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel influenza A.",
keywords = "Novel influenza a (H1N1), Oseltamivir, Zanamivir",
author = "Wie, {Seong Heon} and Kim, {Woo Joo}",
year = "2009",
month = "11",
day = "1",
doi = "10.4082/kjfm.2009.30.11.843",
language = "English",
volume = "30",
pages = "843--847",
journal = "Korean Journal of Family Medicine",
issn = "2005-6443",
publisher = "Korean Academy of Family Medicine",
number = "11",

}

TY - JOUR

T1 - Diagnosis and management of novel influenza a (H1N1)

AU - Wie, Seong Heon

AU - Kim, Woo Joo

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Since the World Health Organization has offi cially declared a global influenza pandemic, the number of human cases of pandemic influenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of influenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel influenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel influenza A.

AB - Since the World Health Organization has offi cially declared a global influenza pandemic, the number of human cases of pandemic influenza A (H1N1) in 2009 has been increasing in many countries. Especially from mid-October, the number of domestic cases of influenza A (H1N1) has been exponentially increasing, with the number of confi rmed cases reaching over 100,000. The clinical symptoms of novel influenza A (H1N1) include fever, cough, sore throat, runny nose, myalgia, headache, chills and fatigue. Nucleic acid amplification tests, including real time RT-PCR assay specific for 2009 novel influenza A (H1N1) can be used in the patients with suspected influenza. Antiviral treatment by using neuraminidase inhibitors (oseltamivir, zanamivir) is recommended by Centers for Disease Control and Prevention for treatment of novel influenza A (H1N1) disease. Personal and public efforts to control the outbreak of novel influenza A (H1N1) disease are required. Vaccination against pandemic H1N1 is important for personal health, but also to build community-level immunity to novel influenza A.

KW - Novel influenza a (H1N1)

KW - Oseltamivir

KW - Zanamivir

UR - http://www.scopus.com/inward/record.url?scp=79961148920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961148920&partnerID=8YFLogxK

U2 - 10.4082/kjfm.2009.30.11.843

DO - 10.4082/kjfm.2009.30.11.843

M3 - Article

AN - SCOPUS:79961148920

VL - 30

SP - 843

EP - 847

JO - Korean Journal of Family Medicine

JF - Korean Journal of Family Medicine

SN - 2005-6443

IS - 11

ER -